Journal of the American Heart Association · 2018 · 71 citations · 16 references
MedicineClinical SciencesSurgeryClinical EpidemiologyComparative EpidemiologyVascular SurgeryThrombosisThrombotic DisordersVascular PathologyPrognostic Factors Analysis
Background Data regarding long-term outcome of patients with thromboangiitis obliterans are lacking and most series come from India and Japan. In this study, we assess long-term outcome and prognostic factors in a large cohort of thromboangiitis obliterans. Methods and Results Retrospective multicenter study of characteristics and outcomes of 224 thromboangiitis obliterans patients fulfilling Papa's criteria were analyzed. Factors associated with vascular events and amputations were identified. The median age at diagnosis was 38.5 (32-46) years, 51 (23.8%) patients were female, and 81.7% were whites. After a mean follow-up of 5.7 years, vascular events were observed in 58.9%, amputations in 21.4%, and death in 1.4%. The 5-, 10-, and 15-year vascular event-free survival and amputation-free survival were 41% and 85%, 23% and 74%, and 19% and 66%, respectively. Ethnic group (nonwhite) (hazard ratio 2.35 [1.30-4.27] P=0.005) and limb infection at diagnosis (hazard ratio 3.29 [1.02-10.6] P=0.045) were independent factors of vascular event-free survival. Factor associated with amputation was limb infection (hazard ratio 12.1 [3.5-42.1], P<0.001). Patients who stopped their tobacco consumption had lower risk of amputation ( P=0.001) than those who continued. Conclusions This nationwide study shows that 34% of thromboangiitis obliterans patients will experience an amputation within 15 years from diagnosis. We identified high-risk patients for vascular complications and amputations.
16
Joseph L. Mills, Michael S. Conte, David G. Armstrong et al. · Journal of Vascular Surgery · 2013 · 1.6K citations · Full text
L. Prompers, Nicolaas C. Schaper, Jan Apelqvist et al. · Diabetologia · 2008 · 1K citations · Full text
The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease).
Jeffrey W. Olin, J R Young, Robert A. Graor et al. · PubMed · 1990 · 273 citations
Clinical and social consequences of buerger disease
Takashi Ohta, Hiroyuki Ishioashi, Minoru Hosaka et al. · Journal of Vascular Surgery · 2003 · 135 citations